Humacyte, Inc. Annual Operating Income (Loss) in USD from 2020 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Humacyte, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
- Humacyte, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$30.2M, a 22.8% decline year-over-year.
- Humacyte, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$112M, a 18.8% decline year-over-year.
- Humacyte, Inc. annual Operating Income (Loss) for 2023 was -$100M, a 18.3% decline from 2022.
- Humacyte, Inc. annual Operating Income (Loss) for 2022 was -$84.6M, a 4.15% decline from 2021.
- Humacyte, Inc. annual Operating Income (Loss) for 2021 was -$81.2M, a 25.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)